Family-owned since 1885 and
driven by the power of our people.
Timeline of Trust
Boehringer Ingelheim Animal Health evolved out of some of the most important milestones in veterinary history.
Albert Boehringer founds a small, family-owned chemical production company in Ingelheim, Germany and names it Boehringer Ingelheim.
Biochemist Marcel Mérieux founds the Institut Biologique Mérieux (Mérieux Biological Institute) in Lyon, France, an early vaccine research and production center and starting point of the future animal health company Merial.
Businessman W. True Davis develops the first vaccine for swine cholera and establishes the Anchor Serum Company in St. Joseph, Missouri.
Boehringer Ingelheim formally establishes its animal health division after acquiring another company's veterinary program.
Boehringer Ingelheim expands animal health operations into the U.S. with the acquisition of Philips Roxane, a pharmaceutical manufacturer that in 1959 had acquired the Anchor Serum Company.
Animal health company Merial is established through the merger of two industry leaders from France and the U.S.
Boehringer Ingelheim acquires Merial, uniting the legacies, deep expertise, and broad product portfolios of the two into one of the world's leading animal health companies.
Coast-to-Coast Animal Care
More than 3,000 people power Boehringer Ingelheim Animal Health in the United States, focused on preventing disease and championing innovation. A part of a larger, family-owned company with a rich global history, Boehringer Ingelheim lives at the intersection of the bond that people and animals share.